Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dianne M Sharp"'
Publikováno v:
Clinical & Experimental Ophthalmology. 35:24-31
Purpose: To assess the efficacy and safety of photodynamic therapy (PDT) for choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) and other conditions by analysing visual acuity changes. Methods: A retrospective revi
Autor:
Ariana Hemara-Wahanui, Jennifer I. Sissingh, Dianne M Sharp, Carolyn I. Hope, Patricia Lundon, Ed A. Mitchell, Gillian M. Clover, Marion A. Maw
Publikováno v:
Clinical and Experimental Ophthalmology. 33:129-136
Purpose: To describe the phenotype in a New Zealand family with an unusual severe X-linked retinal disorder with a novel I745T mutation in CACNA1F, the gene responsible for incomplete congenital stationary night blindness (CSNB2). Methods: Members of
Autor:
Gary Acton, Michael B. Jameson, Paul Thompson, Bruce C. Baguley, Susan Waller, Colin Green, Mark Jeffery, Jennifer I. Sissingh, Mark J. McKeage, Dianne M. Sharp, Christopher R. Hogg
Publikováno v:
Investigative ophthalmologyvisual science. 50(6)
PURPOSE. 5,6-Dimethylxanthenone-4-acetic acid (DMXAA), an anticancer vascular-disrupting agent, has induced transient visual symptoms in some patients. Exploratory investigations were undertaken to characterize the visual disturbances in two consecut
Autor:
Gillian M. Clover, Jörg Striessnig, Jane C. Wilson-Wheeler, Patricia Lundon-Treweek, Marion A. Maw, Peter K. Dearden, Rainer Marksteiner, Jean-Charles Hoda, Dianne M. Sharp, Steffen Hering, Carolyn I. Hope, Stanislav Berjukow, Shu-Biao Wu, Ariana Hemara-Wahanui
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 102(21)
Light stimuli produce graded hyperpolarizations of the photoreceptor plasma membrane and an associated decrease in a voltagegated calcium channel conductance that mediates release of glutamate neurotransmitter. The Ca v 1.4 channel is thought to be i
Publikováno v:
Clinical & Experimental Ophthalmology. 35:585-586
Metronidazole is a little known cause of drug-induced optic neuropathy. We report a patient who developed progressive visual loss after an 8-month course of Metronidazole. Electrophysiology confirmed a bilateral optic neuropathy. Her vision improved
Autor:
M. Clare Robertson, Leigh Hale, Gordon F Sanderson, Robert J. Jacobs, Ngaire Kerse, Dianne M Sharp, Steven La Grow, A. John Campbell
Publikováno v:
BMJ. 331:817
Objectives To assess the efficacy and cost effectiveness of a home safety programme and a home exercise programme to reduce falls and injuries in older people with low vision. Design Randomised controlled trial. Setting Dunedin and Auckland, New Zeal